Oncology Central

How could imaging reduce therapy-associated morbidity in rhabdomyosarcoma of the bladder or prostate?


The treatment of pediatric rhabdomyosarcoma (RMS) of the pelvis has been changing in recent years. Local treatment after chemotherapy is delayed or even avoided completely without effecting overall survival. Imaging is playing a growing role in individualized treatment planning in these patients. In cases of questionable recurrence or residual disease, fusion biopsies may allow a safe and reliable bioptic examination.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.